- Trials with a EudraCT protocol (67)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (7)
67 result(s) found for: Rifampicin.
Displaying page 1 of 4.
| EudraCT Number: 2016-003347-10 | Sponsor Protocol Number: PXR-HDL | Start Date*: 2017-01-16 |
| Sponsor Name:Oulu University Hospital, Internal Medicine Research Unit | ||
| Full Title: The effects of PXR activation on HDL-cholesterol | ||
| Medical condition: Healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FI (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-000632-27 | Sponsor Protocol Number: PORT-01 | Start Date*: 2022-08-03 |
| Sponsor Name:Radboud University Medical Center | ||
| Full Title: Pragmatic trial on the safety and tolerability of an optimized dose of rifampicin in tuberculosis patients | ||
| Medical condition: Tuberculosis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) DK (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-019727-55 | Sponsor Protocol Number: MRSA-2010 | Start Date*: 2010-08-17 |
| Sponsor Name: | ||
| Full Title: Eradikeringsbehandling av MRSA- en jämförelse av kombinerad systemisk antibiotikabehandling och lokal mupirocinbehandling med enbart mupirocin för att eradikera MRSA vid svalgbärarskap | ||
| Medical condition: MRSA-bärarskap | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-005843-24 | Sponsor Protocol Number: RIFA+UDCA | Start Date*: 2006-02-23 |
| Sponsor Name:Hanns-Ulrich Marschall | ||
| Full Title: Studie på effekten av rifampicin och ursodeoxycholsyra på gallipider och deras transport och avgiftning hos patienter med kolesterolgallstenar. | ||
| Medical condition: Gallstone disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003146-36 | Sponsor Protocol Number: RIAlta-1 | Start Date*: 2023-11-15 |
| Sponsor Name:Vall d'Hebron Research Institute (VHIR) | ||
| Full Title: Safety of Rifampicin at High Dose for the Treatment of Adult Subjects with Complex Drug Susceptible Pulmonary and Extrapulmonary Tuberculosis | ||
| Medical condition: Pulmonary and extrapulmonary tuberculosis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001525-10 | Sponsor Protocol Number: bins1 | Start Date*: 2013-07-30 |
| Sponsor Name:Erasmus MC | ||
| Full Title: Studying the metabolism of sorafenib (Nexavar®) by OATP1B blockage in adult cancer patients | ||
| Medical condition: Cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-005078-10 | Sponsor Protocol Number: FARM7X9F8K | Start Date*: 2008-10-20 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA VINCENZO MONALDI DI NAPOLI | |||||||||||||
| Full Title: RANDOMISED, OPEN-LABEL CLINICAL TRIAL ON THE EFFICACY OF COLISTIN PLUS RIFAMPICIN TREATMENT VERSUS COLISTIN ALONE FOR SEVERE INFECTIONS BY MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII | |||||||||||||
| Medical condition: Severe nosocomial infections due to multi-drug resistant Acinetobacter baumannii | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-000938-20 | Sponsor Protocol Number: 2019-5172 | Start Date*: 2021-04-15 |
| Sponsor Name:Radboudumc | ||
| Full Title: Pharmacokinetic study of minocycline in patients with pulmonary nontuberculous mycobacterial disease | ||
| Medical condition: Pulmonary disease caused by Mycobacterium avium complex. Mycobacterium avium complex is a nontuberculous mycobacterium. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-001626-22 | Sponsor Protocol Number: RML-TB | Start Date*: 2022-03-28 |
| Sponsor Name:Vall d'Hebron Institute of Research | ||
| Full Title: A Multicentre Controlled Open Randomized Clinical Trial to evaluate the efficacy and safety profile of an anti-TB drug combination based on High Dose Rifampicin, High Dose Moxifloxacin and Linezoli... | ||
| Medical condition: Smear-positive rifampicin-sensitive pulmonary Tuberculosis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-000344-10 | Sponsor Protocol Number: | Start Date*: 2012-05-24 | |||||||||||||||||||||||||||||||
| Sponsor Name:Medical Research Council [...] | |||||||||||||||||||||||||||||||||
| Full Title: Adjunctive Rifampicin to Reduce Early mortality from Staphylococcus aureus bacteraemia: a randomised controlled trial | |||||||||||||||||||||||||||||||||
| Medical condition: S. aureus bacteraemia | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2020-003169-20 | Sponsor Protocol Number: 20-AOI-03 | Start Date*: 2020-10-20 | |||||||||||
| Sponsor Name:CHU de Nice | |||||||||||||
| Full Title: Efficacy of dalbavancin during osteo-articular infections associated with hip and knee prostheses | |||||||||||||
| Medical condition: Osteo-articular infections | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-004011-44 | Sponsor Protocol Number: UofATURRIFIC | Start Date*: 2020-05-20 |
| Sponsor Name:The University of Adelaide | ||
| Full Title: A randomised trial of URsodeoxycholic acid versus RIFampicin in severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC study, comparing their effectiveness in the reduction of pruri... | ||
| Medical condition: Intrahepatic Cholestasis of Pregnancy (ICP) is an serious liver condition in pregnancy. The main symptom of this is itching. Ursodeoxycholic acid is routinely used to treat cholestasis but is not... | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: FI (Ongoing) GB (GB - no longer in EU/EEA) SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-001276-56 | Sponsor Protocol Number: AIDA | Start Date*: 2014-07-11 |
| Sponsor Name:North Bristol NHS - Southmead Hospital | ||
| Full Title: A prospective, open label, randomised controlled clinical trial, with pharmacokinetic-pharmacodynamic validation, to compare antimicrobial treatment with oral minocycline plus rifampicin to treatme... | ||
| Medical condition: Complicated Skin and Skin Structure infections caused by Methicillin Resistant Staphylococcus Aureus | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: IT (Completed) GR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-003721-25 | Sponsor Protocol Number: High-shortRP | Start Date*: 2020-02-03 | |||||||||||
| Sponsor Name:Region Östergötland | |||||||||||||
| Full Title: Randomized prospective phase II clinical trial investigating pharmacokinetics and safety aspects of higher doses of rifampicin and pyrazinamide in an shortened tuberculosis treatment compared to st... | |||||||||||||
| Medical condition: Tuberculosis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2011-005522-22 | Sponsor Protocol Number: Rifa-BP | Start Date*: 2012-01-23 |
| Sponsor Name:Oulu University Hospital, Department of Internal Medicine | ||
| Full Title: The effects of PXR activation on blood pressure regulation | ||
| Medical condition: Healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-000471-20 | Sponsor Protocol Number: RIPH_2019_01 | Start Date*: 2020-11-30 | |||||||||||
| Sponsor Name:CH Tourcoing | |||||||||||||
| Full Title: Rifabutin versus rifampicin for treatment of staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy): a multicenter randomized, open-la... | |||||||||||||
| Medical condition: Adult with an staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-003786-28 | Sponsor Protocol Number: PERC2015 | Start Date*: 2016-01-19 |
| Sponsor Name:Radboudumc | ||
| Full Title: Pulmonary NTM disease: A regimen of ethambutol and azithromycin with as adjunctive rifampicin vs clofazimine. | ||
| Medical condition: Fibrocavitary pulmonary disease caused by M.avium complex | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-023776-52 | Sponsor Protocol Number: Lisette-1 | Start Date*: 2011-01-19 | |||||||||||
| Sponsor Name: | |||||||||||||
| Full Title: Optimizing tamoxifen therapy through the induction of CYP3A4, CYP2C and CYP2D6 mediated metabolism | |||||||||||||
| Medical condition: Breast cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-002871-32 | Sponsor Protocol Number: Rifabupre | Start Date*: 2012-08-28 |
| Sponsor Name:Turku University hospital | ||
| Full Title: Effects of rifampicin on the pharmacokinetics and pharmacodynamics of sublingual and intravenous buprenorphine: A four-phase cross-over study in healthy subjects. | ||
| Medical condition: Healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FI (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-013704-31 | Sponsor Protocol Number: Rifampisiini01 | Start Date*: 2009-08-17 |
| Sponsor Name:Oulu University Hospital, Department of Internal Medicine | ||
| Full Title: PXR-agonisti rifampisiinin vaikutukset glukoosi-, lipidi- ja hormonihomeostaasiin | ||
| Medical condition: Terveitä vapaaehtoisia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FI (Completed) | ||
| Trial results: View results | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
